Halogenated pyrazolo [1,5-a]pyrimidines, processes, uses as GABA-A receptors ligand, compositions and intermediates

Details for Australian Patent Application No. 2006261025 (hide)

Owner Ferrer Internacional, S.A.

Inventors Guglietta, Antonio; Anglada, Luis; Palomer, Albert

Agent Shelston IP

Pub. Number AU-B-2006261025

PCT Pub. Number WO2006/136530

Priority 60/692,866 21.06.05 US; 05105478.1 21.06.05 EP

Filing date 15 June 2006

Wipo publication date 28 December 2006

Acceptance publication date 8 September 2011

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61P 25/08 (2006.01) Drugs for disorders of the nervous system

A61P 25/20 (2006.01) Drugs for disorders of the nervous system

A61P 25/22 (2006.01) Drugs for disorders of the nervous system

C07C 211/21 (2006.01) Compounds containing amino groups bound to a carbon skeleton

Event Publications

7 February 2008 PCT application entered the National Phase

  PCT publication WO2006/136530 Priority application(s): WO2006/136530

8 September 2011 Application Accepted

  Published as AU-B-2006261025

19 January 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006261029-Process for modifying inorganic oxygen-containing particulate material, product obtained therefrom, and use thereof

2006260997-( 6-flu0r0-benz0[l, 3] dioxolyl) - morpholin-4-yl-methanones and their use as CBI ligands